We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+1.85%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
AUM
$4.01B
AUM Growth
-$55.8M
Cap. Flow
-$77.9M
Cap. Flow %
-1.94%
Top 10 Hldgs %
16.78%
Holding
730
New
81
Increased
176
Reduced
283
Closed
57

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$32.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$28.3M
3
VZ icon
Verizon
VZ
+$26.7M
4
LOW icon
Lowe's Companies
LOW
+$25.6M
5
CMI icon
Cummins
CMI
+$20.9M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$38.5M
2
CL icon
Colgate-Palmolive
CL
+$31.6M
3
LLY icon
Eli Lilly
LLY
+$30.3M
4
HD icon
Home Depot
HD
+$28.5M
5
MSFT icon
Microsoft
MSFT
+$25.1M

Sector Composition

Rank Sector Weight
1 Healthcare 17.88%
2 Technology 13.15%
3 Financials 10.92%
4 Communication Services 10.03%
5 Industrials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMN icon
401
AMN Healthcare
AMN
$1.3B
$639K 0.02%
15,995
+45
+0.3% +$1.67K
LAZ icon
402
Lazard
LAZ
$4.13B
$637K 0.02%
21,400
-300
-1% -$10.4K
AVNT icon
403
Avient
AVNT
$3.33B
$634K 0.02%
18,004
+100
+0.6% +$3.53K
WRI
404
DELISTED
Weingarten Realty Investors
WRI
$630K 0.02%
15,440
-1,406
-8% -$53.4K
TKC icon
405
Turkcell
TKC
$4.68B
$620K 0.02%
+67,800
New +$646K
IBN icon
406
ICICI Bank
IBN
$108B
$619K 0.02%
94,820
MAT icon
407
Mattel
MAT
$4.38B
$615K 0.02%
19,666
-6,250
-24% -$198K
PCY icon
408
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.38B
$614K 0.02%
20,765
+5,975
+40% +$171K
BCR
409
DELISTED
CR Bard Inc.
BCR
$603K 0.02%
2,564
-400
-13% -$86.9K
ATO icon
410
Atmos Energy
ATO
$28.8B
$602K 0.02%
7,408
+601
+9% +$44.6K
IBMI
411
DELISTED
iShares iBonds Sep 2020 Term Muni Bond ETF
IBMI
$598K 0.01%
23,028
+477
+2% +$12.3K
NTT
412
DELISTED
Nippon Telegraph & Telephone
NTT
$596K 0.01%
12,666
+2,804
+28% +$125K
ACWX icon
413
iShares MSCI ACWI ex US ETF
ACWX
$11.5B
$592K 0.01%
15,188
FIS icon
414
Fidelity National Information Services
FIS
$23.1B
$588K 0.01%
7,979
+800
+11% +$56.3K
SSL icon
415
Sasol
SSL
$7.5B
$583K 0.01%
+21,500
New +$632K
CBM
416
DELISTED
Cambrex Corporation
CBM
$583K 0.01%
11,272
-2,225
-16% -$106K
AZO icon
417
AutoZone
AZO
$49.2B
$580K 0.01%
730
UAL icon
418
United Airlines
UAL
$39.4B
$578K 0.01%
14,076
+1,121
+9% +$53K
TEN
419
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$573K 0.01%
12,295
+1,620
+15% +$83K
TVPT
420
DELISTED
Travelport Worldwide Limited
TVPT
$568K 0.01%
+44,030
New +$591K
POR icon
421
Portland General Electric
POR
$5.71B
$563K 0.01%
12,755
+5,010
+65% +$204K
TDAY
422
USA Today Co
TDAY
$1.27B
$558K 0.01%
30,880
KOP icon
423
Koppers
KOP
$943M
$555K 0.01%
18,070
-4,170
-19% -$108K
HCA icon
424
HCA Healthcare
HCA
$87.2B
$553K 0.01%
7,175
ADM icon
425
Archer Daniels Midland
ADM
$38.2B
$551K 0.01%
12,849

Similar funds

Boston Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, Boston Advisors held 730 positions worth $4.01B, down 1.4% from $4.06B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Advisors's Q2 2016 filing shows 81 new, 176 increased, 283 reduced and 57 closed positions. Its largest new stake was Sherwin-Williams: 204,480 shares worth $20M. The largest sale was AbbVie, an estimated $38.5M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

  • Boston Advisors's largest Q2 2016 buy was Sherwin-Williams: 204,480 shares worth $20M.
  • Boston Advisors added most to Biogen in Q2 2016, an estimated $32.1M increase.
  • Boston Advisors's biggest Q2 2016 reduction was AbbVie, cutting an estimated $38.5M.
  • Boston Advisors fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $23.4M.
  • Boston Advisors's ten largest holdings make up 17% of its $4.01B portfolio in Q2 2016.
  • Boston Advisors opened 81 new positions and closed 57 in Q2 2016.
  • Boston Advisors's portfolio value fell 1.4% quarter-over-quarter to $4.01B.

Based on Boston Advisors's 13F filing for Q2 2016, filed 26 Jul 2016.